BSE Live
Apr 20, 16:01Prev. Close
2229.75
Open Price
2254.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 20, 15:45Prev. Close
2226.60
Open Price
2226.60
Bid Price (Qty.)
2299.30 (2)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of NGL Fine Chem (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 354.30 | 324.23 | 270.63 | 313.99 | 258.18 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 354.30 | 324.23 | 270.63 | 313.99 | 258.18 | |
| Total Operating Revenues | 359.29 | 328.97 | 275.05 | 318.67 | 258.18 | |
| Other Income | 9.76 | 15.90 | 7.61 | 12.64 | 8.55 | |
| Total Revenue | 369.05 | 344.87 | 282.66 | 331.31 | 266.73 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 183.80 | 166.58 | 116.58 | 170.35 | 100.64 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 1.36 | -12.06 | 23.29 | -22.03 | 1.86 | |
| Employee Benefit Expenses | 50.71 | 41.32 | 34.25 | 33.05 | 27.23 | |
| Finance Costs | 2.31 | 1.34 | 1.20 | 1.56 | 1.84 | |
| Depreciation And Amortisation Expenses | 9.27 | 8.15 | 7.90 | 7.67 | 7.39 | |
| Other Expenses | 97.73 | 88.83 | 72.85 | 71.73 | 51.76 | |
| Total Expenses | 345.17 | 294.17 | 256.07 | 262.33 | 190.73 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 23.88 | 50.71 | 26.60 | 68.97 | 76.00 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 23.88 | 50.71 | 26.60 | 68.97 | 76.00 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 5.60 | 11.13 | 7.20 | 17.15 | 19.12 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.41 | 0.78 | -0.73 | -0.42 | 1.46 | |
| Tax For Earlier Years | -0.26 | 0.29 | 0.01 | 0.00 | -0.05 | |
| Total Tax Expenses | 5.75 | 12.19 | 6.48 | 16.73 | 20.53 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 18.13 | 38.52 | 20.12 | 52.25 | 55.47 | |
| Profit/Loss From Continuing Operations | 18.13 | 38.52 | 20.12 | 52.25 | 55.47 | |
| Profit/Loss For The Period | 18.13 | 38.52 | 20.12 | 52.25 | 55.47 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 29.35 | 62.35 | 32.56 | 84.57 | 89.79 | |
| Diluted EPS (Rs.) | 29.35 | 62.35 | 32.56 | 84.57 | 89.79 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 45.94 | 46.48 | 31.22 | 35.98 | 23.72 | |
| Indigenous Raw Materials | 137.86 | 120.10 | 85.36 | 134.37 | 76.92 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 2.88 | 2.50 | 1.71 | 2.80 | 1.87 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 1.08 | 1.08 | 1.08 | 1.08 | 1.08 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 35.00 | 35.00 | 35.00 | 35.00 | 35.00 |
05.02.2026
NGL Fine Chem Consolidated December 2025 Net Sales at Rs 127.51 crore, up 43.11% Y-o-Y
04.02.2026
NGL Fine Chem Standalone December 2025 Net Sales at Rs 126.33 crore, up 45.49% Y-o-Y
26.11.2025
NGL Fine Chem Consolidated September 2025 Net Sales at Rs 120.26 crore, up 28.64% Y-o-Y
13.11.2025
NGL Fine Chem Standalone September 2025 Net Sales at Rs 116.84 crore, up 27.82% Y-o-Y
05.02.2026
NGL Fine Chem Consolidated December 2025 Net Sales at Rs 127.51 crore, up 43.11% Y-o-Y
04.02.2026
NGL Fine Chem Standalone December 2025 Net Sales at Rs 126.33 crore, up 45.49% Y-o-Y
26.11.2025
NGL Fine Chem Consolidated September 2025 Net Sales at Rs 120.26 crore, up 28.64% Y-o-Y
13.11.2025
NGL Fine Chem Standalone September 2025 Net Sales at Rs 116.84 crore, up 27.82% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth